158 related articles for article (PubMed ID: 12167464)
1. Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1) receptor.
Anthes JC; Gilchrest H; Richard C; Eckel S; Hesk D; West RE; Williams SM; Greenfeder S; Billah M; Kreutner W; Egan RE
Eur J Pharmacol; 2002 Aug; 449(3):229-37. PubMed ID: 12167464
[TBL] [Abstract][Full Text] [Related]
2. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.
Kreutner W; Hey JA; Anthes J; Barnett A; Young S; Tozzi S
Arzneimittelforschung; 2000 Apr; 50(4):345-52. PubMed ID: 10800633
[TBL] [Abstract][Full Text] [Related]
3. Changes in pH differently affect the binding properties of histamine H1 receptor antagonists.
Gillard M; Chatelain P
Eur J Pharmacol; 2006 Jan; 530(3):205-14. PubMed ID: 16388798
[TBL] [Abstract][Full Text] [Related]
4. Desloratadine inhibits constitutive and histamine-stimulated nuclear factor-kappaB activity consistent with inverse agonism at the histamine H1 Receptor.
Wu RL; Anthes JC; Kreutner W; Harris AG; West RE
Int Arch Allergy Immunol; 2004 Dec; 135(4):313-8. PubMed ID: 15564772
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of [3H]-pyrilamine binding and of the histamine-induced inositol phosphates generation, intracellular Ca2+ -mobilization and cytokine release from human corneal epithelial cells.
Sharif NA; Wiernas TK; Griffin BW; Davis TL
Br J Pharmacol; 1998 Nov; 125(6):1336-44. PubMed ID: 9863665
[TBL] [Abstract][Full Text] [Related]
6. Route to Prolonged Residence Time at the Histamine H
Bosma R; Wang Z; Kooistra AJ; Bushby N; Kuhne S; van den Bor J; Waring MJ; de Graaf C; de Esch IJ; Vischer HF; Sheppard RJ; Wijtmans M; Leurs R
J Med Chem; 2019 Jul; 62(14):6630-6644. PubMed ID: 31274307
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of the binding of [3H]-mepyramine to intact human U373 MG astrocytoma cells: evidence for histamine-induced H1-receptor internalisation.
Hishinuma S; Young JM
Br J Pharmacol; 1995 Nov; 116(6):2715-23. PubMed ID: 8590995
[TBL] [Abstract][Full Text] [Related]
9. The noncompetitive antagonism of histamine H1 receptors expressed in Chinese hamster ovary cells by olopatadine hydrochloride: its potency and molecular mechanism.
Matsumoto Y; Funahashi J; Mori K; Hayashi K; Yano H
Pharmacology; 2008; 81(3):266-74. PubMed ID: 18268402
[TBL] [Abstract][Full Text] [Related]
10. BRET-based β-arrestin2 recruitment to the histamine H1 receptor for investigating antihistamine binding kinetics.
Bosma R; Moritani R; Leurs R; Vischer HF
Pharmacol Res; 2016 Sep; 111():679-687. PubMed ID: 27468652
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of GSK1004723, a novel, long-acting antagonist at histamine H(1) and H(3) receptors.
Slack RJ; Russell LJ; Hall DA; Luttmann MA; Ford AJ; Saunders KA; Hodgson ST; Connor HE; Browning C; Clark KL
Br J Pharmacol; 2011 Nov; 164(6):1627-41. PubMed ID: 22022805
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activity of the histamine H(1) receptor reveals inverse agonism of histamine H(1) receptor antagonists.
Bakker RA; Wieland K; Timmerman H; Leurs R
Eur J Pharmacol; 2000 Jan; 387(1):R5-7. PubMed ID: 10633171
[TBL] [Abstract][Full Text] [Related]
13. Discovery of the novel and potent histamine H1 receptor antagonists for treatment of allergic diseases.
Chu Z; Cen L; Xu Q; Lin G; Mo J; Shao L; Zhao Y; Li J; Ye W; Fang T; Ren W; Zhu Q; He G; Xu Y
Eur J Med Chem; 2024 Mar; 268():116197. PubMed ID: 38368709
[TBL] [Abstract][Full Text] [Related]
14. Characterization of histamine type 1 receptors on natural suppressor lymphoid cells.
Khan MM; Wilson AL; Melmon KL
Biochem Pharmacol; 1987 Nov; 36(22):3867-71. PubMed ID: 2891358
[TBL] [Abstract][Full Text] [Related]
15. Characterization of thromboxane A2/prostaglandin H2 receptors and histamine H1 receptors in cultured guinea-pig tracheal smooth-muscle cells.
Miki I; Nonaka H; Ishii A
Biochim Biophys Acta; 1992 Oct; 1137(1):107-15. PubMed ID: 1356444
[TBL] [Abstract][Full Text] [Related]
16. A novel phenylaminotetralin radioligand reveals a subpopulation of histamine H(1) receptors.
Booth RG; Moniri NH; Bakker RA; Choksi NY; Nix WB; Timmerman H; Leurs R
J Pharmacol Exp Ther; 2002 Jul; 302(1):328-36. PubMed ID: 12065734
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of histamine H1- and H2-receptors in guinea-pig left atrial membranes by [3H]-mepyramine and [3H]-tiotidine binding.
Hattori Y; Endou M; Gando S; Kanno M
Br J Pharmacol; 1991 Jun; 103(2):1573-9. PubMed ID: 1909203
[TBL] [Abstract][Full Text] [Related]
18. Effect of desloratadine and loratadine on rhinovirus-induced intercellular adhesion molecule 1 upregulation and promoter activation in respiratory epithelial cells.
Papi A; Papadopoulos NG; Stanciu LA; Degitz K; Holgate ST; Johnston SL
J Allergy Clin Immunol; 2001 Aug; 108(2):221-8. PubMed ID: 11496238
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of depolarization-induced [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells by some second-generation H(1) receptor antagonists through blockade of store-operated Ca(2+) channels (SOCs).
Taglialatela M; Secondo A; Fresi A; Rosati B; Pannaccione A; Castaldo P; Giorgio G; Wanke E; Annunziato L
Biochem Pharmacol; 2001 Nov; 62(9):1229-38. PubMed ID: 11705456
[TBL] [Abstract][Full Text] [Related]
20. High affinity, saturable [3H]mepyramine binding sites on rat liver plasma membrane do not represent histamine H1-receptors. A warning.
Leurs R; Bast A; Timmerman H
Biochem Pharmacol; 1989 Jul; 38(13):2175-80. PubMed ID: 2567596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
